Advertisement

Topics

Latest "Z.Inc" News Stories

14:40 EST 14th December 2018 | BioPortfolio

Here are the most relevant search results for "Z.Inc" found in our extensive news archives from over 250 global news sources.

More Information about Z.Inc on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Z.Inc for you to read. Along with our medical data and news we also list Z.Inc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Z.Inc Companies for you to search.

Showing News Articles 1–25 of 440,000+

Friday 14th December 2018

BIO Statement on Hatch-Waxman Integrity Act of 2018

Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the Hatch-Waxman Integrity Act of 2018: “For almost 40 years, the groundbreaking law known as the Hatch-Waxman Act (HWA) has been highly successful in spurring the development of life-saving new treatments while at the same ...


Cascadian Therapeutics Inc CASC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryCascadian Therapeutics Inc Cascadian, formerly Oncothyreon Inc is a clinicalstage biotechnology company that develops therapeutic products for the treatment of cancer. The company's lead clinicalstage product candidate includes ONT380, an orally active and selective smallmolecule HER2 inhibitor which is intended for the treatment of HER2positive HER2+ metastatic breast cancer. It also devel...

Applied Genetic Technologies Corp AGTC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryApplied Genetic Technologies Corp AGTC is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as xlinked retinoschisis, achromatopsia, xlinked retinitis pigmentosa, alpha1 antitrypsin deficiency and macular degeneration, among others. AGTC's achromatopsia prov...


Subscribe to STAT Plus today to gain exclusive access to STAT@JPM — a free work space during #JPM19 reserved entirely for STAT Plus subscribers. Register here: https://buff.ly/2LhEVhM 

Subscribe to STAT Plus today to gain exclusive access to STAT@JPM — a free work space during #JPM19 reserved entirely for STAT Plus subscribers. Register here: https://buff.ly/2LhEVhM 

Traumatic Pain Global Clinical Trials Review, H2, 2018 [Report Updated: 31082018] Prices from USD $2125

Traumatic Pain Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Traumatic Pain Global Clinical Trials Review, H2, 2018" provides an overview of Traumatic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Traumatic Pain. Report includes an overview of trial numbers and their average enrollment in top countries condu...

TripleTree Advises Consolo Services Group on Acquisition by WellSky

TripleTree, LLC, a strategic advisor and merchant bank serving innovative companies in healthcare, is pleased to announce that its client, Consolo Services Group, a portfolio company of Bluff Point Associates and leading provider of fully-integrated, web-based health IT solutions for the hospice and palliative care industries, has been acquired by WellSky,...

OPKO Health Inc OPK Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryOPKO Health Inc OPKO discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company's product portfolio includes pointofcare tests, laboratory developed tests LDTs, molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers its diagonostics and therapeutics that are used in the treatment of chronic kidney disease...

Nephron Pharmaceuticals Releases Opioid-Free Pain Management Med

NewsThe product, BKK, is a multimodal analgesia containing Bupivacaine, Ketorolac, and Ketamine in three 20mL profiled syringes.Topics: 

J&J shares nosedive on report company knew of asbestos in baby powder

Shares of Johnson & Johnson tumbled 12 percent on Friday and were on track to post their biggest percentage drop in more than 16 years, after Reuters reported that the pharma major knew for decades that cancer-causing asbestos lurked in its Baby Pow...

Hy-Vee buys files from 22 Shopko pharmacies

Worth the sting: Cuba's scorpion pain remedy

Once a month for the last decade, Pepe Casanas, a 78-year-old Cuban farmer, has hunted down a scorpion to sting himself with, vowing that the venom wards off his rheumatism pains.

For These Critically Endangered Marine Turtles, Climate Change Could be a Knockout Blow

NewsA new study shows that this critically endangered species could be at particular risk.Contributed Author: 

Device Makes Detection of Parasitic Infections Faster, More Sensitive

NewsResearchers have developed an inexpensive and portable platform that can rapidly detect motile parasites in bodily fluids automatically.

Rite Aid Foundation’s KidCents Program Donates $50,000 to Hurley Children's Hospital

Renewal Grant Will Support Continuation of Nutrition Prescription Program for At-Risk Children The Rite Aid Foundation announced today a grant of $50,000 to the Hurley Foundation, on behalf of Hurley Children’s Hospital in Flint, Mich., to improve access to healthy foods for underserved children. The grant will support the hospital’s Nutrition Pres...

Global Allergic Rhinitis Drugs Market 2019-2023| Increasing Demand for Over-the-Counter Medicines to Boost Growth| Technavio

The global allergic rhinitis drugs market is expected to post a CAGR of nearly 4% during the period 2019-2023, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005449/en/

A 38-Year-Old With a Neck Mass

A 38-year-old man presents with a mass in the right size of the neck. The mass is not painful. What is your diagnosis?

-#Novartis #CEO wants to 'un-boss' company culture -Feature: #MDMA-assisted psychotherapy -#Trump disrupts #HIV researchers using feotal tissue -Generics companies #investigated over #pharma cartel -Akorn CEO resigns after failure of Fresenius deal

- #Novartis #CEO wants to 'un-boss' company culture -Feature: #MDMA-assisted psychotherapy - #Trump disrupts #HIV researchers using feotal tissue -Generics companies #investigated over

'Significant' health outcomes gap still exists in #Scotland: http://bit.ly/2GhuYC3  #health #NHS

'Significant' health outcomes gap still exists in #Scotland: http://bit.ly/2GhuYC3  #health #NHS

Edmonton to Host Clinical Trial for Nova Oculus Medical Device that Could Help Improve Vision for AMD Sufferers

Health Canada approves study for pioneering treatment EDMONTON, Alberta (PRWEB) December 14, 2018 NOVA OCULUS PARTNERS, LLC, and its Canadian partner, the Eye Machine Canada Inc., have been given the green light to immediately begin a clinical patient trial in Edmonton using their pioneering technology for treating Age-Related Macular Degeneration (AMD). The medical devices bureau of Health Canad...

The world's first gene-edited babies were born in China last month. The same gene-editing tool, applied on animals, has resulted in long tongues, extra bones, dappled fleeces and deaths. My latest @WSJ investigation with @Lucy_Craymer. https://www.wsj.co

The world's first gene-edited babies were born in China last month. The same gene-editing tool, applied on animals, has resulted in long tongues, extra bones, dappled fleeces and deaths. My latest @WSJ investigation with @Lucy_Craymer. https://www.wsj.com/articles/deformities-alarm-scientists-racing-to-rewrite-animal-dna-11544808779 …

Former radiologist receives 2 years in prison for pill scheme

The former University of Pittsburgh Medical Center (UPMC) radiologist convicted of writing prescriptions for non-medical reasons has been sentenced to two years in federal prison, according to a Pittsburgh Post-Gazette report.

Teligent Executes $120 Million Financing Agreement

Teligent (NASDAQ:TLGT) announced today that on December 13, 2018 the Company entered into a definitive first lien revolving credit agreement with ACF Finco I LP, a limited partnership affiliated with Ares Management Corporation, as administrative agent, and the lenders party thereto and a definitive second lien credit agreement with Ares Capital Corporation, as administrative agent, and … C...

Life Science Big News Roundup: NanoSphere Forms Strategic Partnership in Mexico; Chemesis International Inc. Announces Approval of OTCQB Uplisting

In case you missed it, here is this week’s life science big news roundup. The post Life Science Big News Roundup: NanoSphere Forms Strategic Partnership in Mexico; Chemesis International Inc. Announces Approval of OTCQB Uplisting appeared first on Investing News Network.

Idera Pharmaceuticals Presents Clinical Safety and Efficacy Update from the ILLUMINATE-204 Trial

Idera Pharmaceuticals  (NASDAQ:IDRA) is presenting data from the ongoing phase 2 expansion of the ILLUMINATE-204 trial investigating tilsotolimod, Idera’s intratumorally-delivered toll-like receptor 9 (TLR9) agonist, in combination with ipilimumab (Yervoy). As quoted in the press release: “The results from this combination are among the most promising we have seen in this challenging populati...

Quiz: Globally in 2017, what percentage of people living with #HIV knew their HIV status?

Quiz: Globally in 2017, what percentage of people living with #HIV knew their HIV status?


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks